SCHEMBL7501428

SCHEMBL7501428

NS(=O)(=O)c1ccc(-c2oc(Cc3ccccc3)nc2-c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.55
CA2 P00918 6/20 0.55
CA12 O43570 3/20 0.55
CA9 Q16790 3/20 0.55
CA14 Q9ULX7 1/20 0.55
PTGS2 P35354 6/20 0.50
NR4A2 P43354 6/20 0.50
PTGS1 P23219 3/20 0.50
NR4A1 P22736 2/20 0.50
NR4A3 Q92570 2/20 0.50
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
RXRA P19793 4/20 0.48
RXRB P28702 4/20 0.48
RXRG P48443 4/20 0.48
KDM4E B2RXH2 1/20 0.48
ABCC4 O15439 1/20 0.48
C5 P01031 1/20 0.48
LMNA P02545 1/20 0.48
CHRM2 P08172 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7503191 1.00 CA1 (0.55) CA1CA2CA12CA9CA14
SCHEMBL7501237 0.93 PTGS2 (0.61) CA1CA2CA12CA9CA14
SCHEMBL7500801 0.93 RXRA (0.53) CA1CA2CA12CA9CA14
SCHEMBL7503904 0.93 RXRA (0.53) CA1CA2CA12CA9CA14
SCHEMBL7505500 0.93 PTGS2 (0.61) CA1CA2CA12CA9CA14
SCHEMBL7504153 0.93 RXRA (0.53) CA1CA2CA12CA9CA14
SCHEMBL7505978 0.93 RXRA (0.53) CA1CA2CA12CA9CA14
SCHEMBL6026019 0.92 CA1 (0.49) CA1CA2CA12CA9CA14
SCHEMBL7504923 0.90 KDR (0.48) CA1CA2CA12CA9CA14
SCHEMBL7510313 0.90 KDR (0.48) CA1CA2CA12CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 EP claimed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 EP claimed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 WO claimed
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 WO disclosed